Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,752 | 214 | 96.2% |
| Education | $132.88 | 9 | 3.4% |
| Consulting Fee | $14.75 | 1 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AbbVie Inc. | $691.72 | 40 | $0 (2023) |
| PFIZER INC. | $555.34 | 33 | $0 (2022) |
| Lupin Inc. | $497.84 | 36 | $0 (2021) |
| Amgen Inc. | $409.58 | 16 | $0 (2021) |
| Aspira Women's Health Inc | $256.26 | 5 | $0 (2022) |
| Avion Pharmaceuticals | $141.09 | 10 | $0 (2020) |
| AMAG Pharmaceuticals, Inc. | $140.34 | 9 | $0 (2019) |
| Daiichi Sankyo Inc. | $133.99 | 6 | $0 (2021) |
| TherapeuticsMD, Inc. | $123.20 | 7 | $0 (2022) |
| Merck Sharp & Dohme Corporation | $114.13 | 5 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $42.91 | 2 | AbbVie Inc. ($27.58) |
| 2022 | $517.80 | 22 | Aspira Women's Health Inc ($170.96) |
| 2021 | $736.58 | 36 | AbbVie Inc. ($215.21) |
| 2020 | $616.41 | 39 | Lupin Inc. ($187.32) |
| 2019 | $903.74 | 54 | PFIZER INC. ($218.20) |
| 2018 | $558.77 | 38 | PFIZER INC. ($116.50) |
| 2017 | $523.71 | 33 | PFIZER INC. ($92.79) |
All Payment Transactions
224 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/21/2023 | Kowa Pharmaceuticals America, Inc. | SEGLENTIS (Drug) | Food and Beverage | In-kind items and services | $15.33 | General |
| Category: PAIN MANAGEMENT | ||||||
| 03/06/2023 | AbbVie Inc. | LO LOESTRIN FE (Drug) | Food and Beverage | In-kind items and services | $27.58 | General |
| Category: WOMENS HEALTH | ||||||
| 12/13/2022 | MAYNE PHARMA INC. | — | Food and Beverage | In-kind items and services | $11.82 | General |
| 11/29/2022 | ABBVIE INC. | LILETTA (Drug) | Food and Beverage | In-kind items and services | $19.37 | General |
| Category: WOMENS HEALTH | ||||||
| 11/16/2022 | ABBVIE INC. | LO LOESTRIN FE (Drug), ORIAHNN, ORILISSA | Food and Beverage | In-kind items and services | $13.27 | General |
| Category: WOMENS HEALTH | ||||||
| 11/14/2022 | PFIZER INC. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: GENITOURINARY (SEXUAL HEALTH);WOMENS HEALTH | ||||||
| 09/22/2022 | ABBVIE INC. | LO LOESTRIN FE (Drug) | Food and Beverage | In-kind items and services | $14.43 | General |
| Category: WOMENS HEALTH | ||||||
| 09/20/2022 | Aspira Women's Health Inc | OVA1 (Device) | Food and Beverage | In-kind items and services | $87.30 | General |
| Category: OB/GYN | ||||||
| 09/19/2022 | PFIZER INC. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $14.26 | General |
| Category: GENITOURINARY (SEXUAL HEALTH);WOMENS HEALTH | ||||||
| 09/16/2022 | Bausch Health US, LLC | APLENZIN (Drug), WELLBUTRIN | Food and Beverage | In-kind items and services | $13.43 | General |
| Category: Neurology | ||||||
| 09/13/2022 | TherapeuticsMD, Inc. | ANNOVERA (Drug) | Food and Beverage | In-kind items and services | $19.08 | General |
| Category: OBSTETRICS GYNECOLOGY WOMEN'S HEALTH | ||||||
| 08/29/2022 | SCYNEXIS, Inc. | — | Food and Beverage | In-kind items and services | $20.57 | General |
| 07/29/2022 | ABBVIE INC. | LILETTA (Drug) | Food and Beverage | In-kind items and services | $29.08 | General |
| Category: WOMENS HEALTH | ||||||
| 07/21/2022 | Bausch Health US, LLC | APLENZIN (Drug), WELLBUTRIN | Food and Beverage | In-kind items and services | $13.56 | General |
| Category: Neurology | ||||||
| 07/08/2022 | TherapeuticsMD, Inc. | ANNOVERA (Drug) | Food and Beverage | In-kind items and services | $23.79 | General |
| Category: OBSTETRICS GYNECOLOGY WOMEN'S HEALTH | ||||||
| 06/21/2022 | ABBVIE INC. | ORIAHNN (Drug), LO LOESTRIN FE, ORILISSA | Food and Beverage | In-kind items and services | $20.62 | General |
| Category: WOMENS HEALTH | ||||||
| 05/20/2022 | SCYNEXIS, Inc. | — | Food and Beverage | In-kind items and services | $14.51 | General |
| 05/11/2022 | ABBVIE INC. | ORIAHNN (Drug), LO LOESTRIN FE, ORILISSA | Food and Beverage | In-kind items and services | $22.49 | General |
| Category: WOMENS HEALTH | ||||||
| 04/11/2022 | SCYNEXIS, Inc. | — | Food and Beverage | In-kind items and services | $20.67 | General |
| 04/05/2022 | Sage Therapeutics, Inc. | ZULRESSO (Drug) | Food and Beverage | In-kind items and services | $12.55 | General |
| Category: PSYCHIATRYPSYCHOLOGY | ||||||
| 03/08/2022 | Aspira Women's Health Inc | OVA1 (Device) | Food and Beverage | In-kind items and services | $83.66 | General |
| Category: OB/GYN | ||||||
| 02/28/2022 | UROVANT SCIENCES INC | GEMTESA (Drug) | Food and Beverage | Cash or cash equivalent | $18.99 | General |
| Category: Urology | ||||||
| 02/07/2022 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $14.47 | General |
| Category: Oral Contraceptive | ||||||
| 01/10/2022 | PFIZER INC. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $11.78 | General |
| Category: GENITOURINARY (SEXUAL HEALTH);WOMENS HEALTH | ||||||
| 12/14/2021 | UROVANT SCIENCES INC | GEMTESA (Drug) | Food and Beverage | Cash or cash equivalent | $17.82 | General |
| Category: Urology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 267 | 282 | $26,207 | $12,807 |
| 2022 | 5 | 665 | 688 | $46,768 | $27,062 |
| 2021 | 8 | 967 | 1,008 | $81,079 | $38,637 |
| 2020 | 10 | 1,080 | 1,136 | $88,927 | $40,996 |
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 100 | 111 | $12,640 | $5,186 | 41.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 37 | 38 | $5,318 | $3,057 | 57.5% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2023 | 56 | 56 | $3,866 | $1,999 | 51.7% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2023 | 60 | 60 | $3,195 | $1,994 | 62.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 14 | 17 | $1,188 | $571.05 | 48.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 251 | 274 | $24,660 | $14,432 | 58.5% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2022 | 132 | 132 | $6,600 | $4,936 | 74.8% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2022 | 139 | 139 | $5,838 | $4,931 | 84.5% |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | Office | 2022 | 129 | 129 | $6,450 | $2,310 | 35.8% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2022 | 14 | 14 | $3,220 | $452.90 | 14.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 275 | 316 | $28,230 | $17,187 | 60.9% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2021 | 149 | 149 | $7,450 | $5,968 | 80.1% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2021 | 152 | 152 | $6,384 | $5,717 | 89.5% |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | Office | 2021 | 256 | 256 | $12,800 | $4,621 | 36.1% |
| 77080 | Bone density measurement of the core or central skeleton (e.g., hips, pelvis, spine) | Office | 2021 | 95 | 95 | $21,850 | $3,287 | 15.0% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 15 | 15 | $1,875 | $905.42 | 48.3% |
| 76856 | Ultrasound of pelvis, complete, not pregnancy related | Office | 2021 | 12 | 12 | $2,100 | $749.72 | 35.7% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Office | 2021 | 13 | 13 | $390.00 | $201.96 | 51.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 268 | 320 | $25,610 | $14,375 | 56.1% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2020 | 176 | 176 | $7,240 | $6,789 | 93.8% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2020 | 160 | 160 | $8,000 | $6,402 | 80.0% |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | Office | 2020 | 248 | 248 | $12,400 | $4,459 | 36.0% |
| 77080 | Bone density measurement using dedicated x-ray machine | Office | 2020 | 111 | 111 | $25,530 | $4,006 | 15.7% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 36 | 36 | $4,500 | $2,291 | 50.9% |
| 76856 | Ultrasound of pelvis | Office | 2020 | 21 | 25 | $4,375 | $1,664 | 38.0% |
About Dr. John Waterfallen, MD
Dr. John Waterfallen, MD is a Obstetrics & Gynecology healthcare provider based in Shreveport, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/14/2005. The National Provider Identifier (NPI) number assigned to this provider is 1164417309.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Waterfallen, MD has received a total of $3,900 in payments from pharmaceutical and medical device companies, with $42.91 received in 2023. These payments were reported across 224 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($3,752).
As a Medicare-enrolled provider, Waterfallen has provided services to 2,979 Medicare beneficiaries, totaling 3,114 services with total Medicare billing of $119,503. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Practice Information
- Specialty Obstetrics & Gynecology
- Location Shreveport, LA
- Active Since 09/14/2005
- Last Updated 07/08/2007
- Taxonomy Code 207V00000X
- Entity Type Individual
- NPI Number 1164417309
Products in Payments
- SOLOSEC (Drug) $407.81
- Prolia (Biological) $312.27
- PREMARIN (Drug) $294.99
- OVA1 (Device) $256.26
- Orilissa (Drug) $177.85
- LO LOESTRIN FE (Drug) $142.43
- INJECTAFER (Drug) $133.99
- Prenate Mini (Drug) $127.11
- ORILISSA (Drug) $126.94
- INTRAROSA (Drug) $125.59
- CONTRAVE (Drug) $110.25
- ORIAHNN (Drug) $104.56
- LILETTA (Drug) $98.09
- Dayvigo (Drug) $92.79
- SOLOSEC-CEEK (Drug) $90.03
- EVENITY (Biological) $88.29
- PREMARIN ORALS (Drug) $78.66
- COLOGUARD (Device) $76.47
- BELSOMRA (Drug) $75.08
- MYFEMBREE (Drug) $58.80
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Obstetrics & Gynecology Doctors in Shreveport
Dani Zoorob, Md, MD
Obstetrics & Gynecology — Payments: $186,654
Catherine Vanderloos, Md, MD
Obstetrics & Gynecology — Payments: $132,440
Dr. Andrew Green, M.d, M.D
Obstetrics & Gynecology — Payments: $83,549
Dr. Ricky Paul, Md, MD
Obstetrics & Gynecology — Payments: $22,748
James Robertson, Md, MD
Obstetrics & Gynecology — Payments: $12,426
John Haynes, Md, MD
Obstetrics & Gynecology — Payments: $8,149